Immunogenicity of BNT162b2 Vaccine in Patients with Inflammatory Bowel Disease on Infliximab Combination Therapy: A Multicenter Prospective Study

por Shehab, Mohammad, Abu-Farha, Mohamed, Alrashed, Fatema, Alfadhli, Ahmad, Alotaibi, Khazna, Alsahli, Abdullah, Alphonse Thanaraj, Thangavel, Channanath, Arshad, Ali, Hamad, Abubaker, Jehad, Almulla, Fahd
Publicado 2021

Relevance between COVID-19 and host genetics of immune response

por Taher, Ibrahim, Almaeen, Abdulrahman, Ghazy, Amany, Abu-Farha, Mohamed, Mohamed Channanath, Arshad, Elsa John, Sumi, Hebbar, Prashantha, Arefanian, Hossein, Abubaker, Jehad, Al-Mulla, Fahd, Alphonse Thanaraj, Thangavel
Publicado 2021

Serological Response to BNT162b2 and ChAdOx1 nCoV-19 Vaccines in Patients with Inflammatory Bowel Disease on Biologic Therapies

por Shehab, Mohammad, Alrashed, Fatema, Alfadhli, Ahmad, Alotaibi, Khazna, Alsahli, Abdullah, Mohammad, Hussain, Cherian, Preethi, Al-Khairi, Irina, Alphonse Thanaraj, Thangavel, Channanath, Arshad, Ali, Hamad, Abu-Farha, Mohamed, Abubaker, Jehad, Al-Mulla, Fahd
Publicado 2021